FlowMAb FITC anti-mouse/human CD11b

Catalog #FM0007-FITC
Clone:
M1/70
Reactivities:
Mouse, Human
As low as $240.00

$240.00 - $350.00

$240.00 - $350.00

Choose an Option...
  • 100 µg - $350.00
  • 25 µg - $240.00
In stock
Only %1 left

Product Details

The M1/70 monoclonal antibody reacts with mouse and human CD11b, a 170 kDa membrane glycoprotein also known as integrin alpha M (ITGAM). CD11b belongs to the integrin alpha family and is primarily expressed on granulocytes and monocytes/macrophages but also expressed on dendritic cells, NK cells, and subsets of T and B cells. CD11b and CD18 combine to form Mac-1 integrin, which is also known as complement receptor 3 (CR3). Mac-1 functions as a complement receptor as well as a receptor for fibrinogen, factor X, and ICAM1. This fluorescein isothiocyanate (FITC)-conjugated version of the M1/70 antibody is useful for flow cytometry.

Specifications

Isotype Rat IgG2b,Ā Īŗ
Conjugation FITC
Excitation Source Blue 488 nm
Excitation Max 494 nm
Emission Max 518 nm
Immunogen B10 mouse spleen cells enriched for T cells
Reported Applications Flow cytometry
Formulation PBS, pH 7.0
Contains 0.09% Sodium Azide
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein G. Conjugated with fluorescein isothiocyanate under optimal conditions.
Storage The antibody solution should be stored at the stock concentration at 4Ā°C and protected from prolonged exposure to light. Do not freeze.
Flow Cytometry
Becker, A. M., et al. (2015). "ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors" Exp Hematol 43(1): 44-52 e41-43. PubMed

All-lymphoid progenitors (ALPs) yield few myeloid cells in vivo, but readily generate such cells in vitro. The basis for this difference remains unknown. We hypothesized that ALPs limit responsiveness to in vivo concentrations of myeloid-promoting cytokines by reducing expression of the corresponding receptors, potentially through posttranscriptional mechanisms. Consistent with such a mechanism, ALPs express higher levels of CSF1R transcripts than their upstream precursors, yet show limited cell-surface protein expression of colony-stimulating factor 1 receptor (CSF1R). All-lymphoid progenitors and other hematopoietic progenitors deficient in A disintegrin and metalloproteinase domain 17 (ADAM17), display elevated cell surface CSF1R expression. ADAM17(-/-) ALPs, however, fail to yield myeloid cells upon transplantation into irradiated recipients. Moreover, ADAM17(-/-) ALPs yield fewer macrophages in vitro than control ALPs at high concentrations of macrophage colony stimulating factor. Mice with hematopoietic-specific deletion of ADAM17 have normal numbers of myeloid and lymphoid progenitors and mature cells in vivo. These data demonstrate that ADAM17 limits CSF1R protein expression on hematopoietic progenitors, but that compensatory mechanisms prevent elevated CSF1R levels from altering lymphoid progenitor potential.